Report Highlights
The global market for cryostat microtome should grow from $43.4 million in 2019 to $60.6 million by 2024 with a compound annual growth rate (CAGR) of 6.9% for the period of 2019-2024.
Report Includes
- 42 tables
- An overview of global cryostat microtome equipment market
- Analyses of global market trends with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Discussion of potential application areas of cryostat microtome equipment in medical care and biology research centers
- Comparative study on manual, semi-automatic and automatic cryostat microtome and discussion on their advantages
- Comprehensive profiles of the major players of the market, including Alltion (Wuzhou) Co. Ltd., Bright Instruments Ltd., Freezers India, Sigma Scientific Glass Co., Jinhua Yidi Medical Appliance Co., Ltd., and Thermo Fisher Scientific Inc.
Report Scope
The scope of this report is broad and covers global cryostat microtome equipment used for various applications in the global medical industry. The market is broken down by type, application and region. Revenue forecasts from 2019 to 2024 are presented for each product type, application segment and regional market.
The report also includes a discussion on the major players in each of the regional markets for cryostat microtome. It explains the major market drivers of the global cryostat microtome market, the current trends within the industry and the regional dynamics of the cryostat microtome market. The report concludes with a special focus on the vendor landscape.
Analyst Credentials
Aneesh Kumar has been a project manager and partner with BizImpact Knowledge Services, LLP, a market research and services company primarily focused on opportunities in science and technology, since 2011. Kumar manages a team focused on global market research projects, primary interviews and market forecasting. He holds a BBA from the Institute of Chartered Financial Analysts of India and is a member of the Indo-German Chambers of Commerce.
Related Reports
Medical Robotics and Computer-assisted Surgery: The Global Market
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Cell and Tissue Analysis
The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.
Microscopy: The Global Market
The global market for microscopes, accessories and supplies reached $7.1 billion in 2019 and should reach $9.8 billion by 2024, at a compound annual growth rate (CAGR) of 6.6% for the period of 2019-2024.
Recent Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More